Sunitinib and mucosal inflammation Patient Reports February 12, 2012
Sunitinib Side Effects Report #6080620-1
Sunitinib side effect was reported by a Health Professional from FRANCE on Feb 04, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Sunitinib. After drug was administered, patient experienced the following side effects: asthenia, mucosal inflammation, renal failure acute. Sunitinib dosage: unknown. During the same period patient was treated with MODURETIC, SELOKEN, TOPALGIC, SOPHIDONE, OXYNORM, HALDOL. Patient was hospitalized. Patient recovered.
Sunitinib Side Effects Report #6133836-X
Sunitinib side effect was reported by a Health Professional from FRANCE on Mar 16, 2009. Female patient was diagnosed with non-small cell lung cancer and was treated with Sunitinib. After drug was administered, patient experienced the following side effects: mucosal inflammation, renal failure acute. Sunitinib dosage: unknown. During the same period patient was treated with MODURETIC, SELOKEN, TOPALGIC, SOPHIDONE, OXYNORM, HALDOL. Patient was hospitalized. Patient recovered.
Sunitinib Side Effects Report #5648722-9
Sunitinib side effect was reported by a Health Professional from UNITED STATES on Mar 03, 2008. Female patient, weighting 114.0 lb, was diagnosed with neoplasm malignant and was treated with Sunitinib. After drug was administered, patient experienced the following side effects: cardiac arrest
, dehydration, failure to thrive, lymphadenopathy, mucosal inflammation, pain
, pericardial effusion, pneumonia aspiration, respiratory failure. Sunitinib dosage: 37.5MG/ DAY/ ORAL/ PILL. During the same period patient was treated with NEURONTIN, OXYCODONE, PREDNISONE, PRILOSEC, NEXIUM. Patient was hospitalized. Patient died on 02/05/2008.Sunitinib Side Effects Report #6100303-9
Sunitinib side effect was reported by a Physician from POLAND on Feb 19, 2009. Female patient was diagnosed with metastatic renal cell carcinoma and was treated with Sunitinib. After drug was administered, patient experienced the following side effects: mucosal inflammation, renal failure. Sunitinib dosage: 50 MG, 1X/DAY. During the same period patient was treated with KETONAL, DURAGESIC. Patient was hospitalized. Patient died on 06/10/2006.
Sunitinib Side Effects Report #6107581-0
Sunitinib side effect was reported by a Physician from ITALY on Feb 27, 2009. Female patient was diagnosed with metastatic renal cell carcinoma, mood altered, agitation and was treated with Sunitinib. After drug was administered, patient experienced the following side effects: confusional state, haematemesis, mucosal inflammation. Sunitinib dosage: 50 MG, 1X/DAY. During the same period patient was treated with MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE, NORVASC, LAMICTAL, CARDIRENE, RYTMONORM, LANSOX, MEDROL. Patient was hospitalized. Patient died on 09/02/2006.
Sunitinib Side Effects Report #6035371-6
Sunitinib side effect was reported by a Health Professional from UNITED STATES on Jan 09, 2009. Male patient, 46 years of age, weighting 171.0 lb, was diagnosed with malignant melanoma and was treated with Sunitinib. After drug was administered, patient experienced the following side effects: decreased appetite, dehydration, febrile neutropenia, food intolerance, hypophagia, mucosal inflammation. Sunitinib dosage: 37.5MG/DAILY, ORAL. During the same period patient was treated with PERCOCET, ASPIRIN. Patient was hospitalized. Patient recovered.
Sunitinib Side Effects Report #6037908-X
Sunitinib side effect was reported by a Health Professional from UNITED STATES on Jan 13, 2009. Male patient, 46 years of age, weighting 171.0 lb, was diagnosed with malignant melanoma and was treated with Sunitinib. After drug was administered, patient experienced the following side effects: decreased appetite, dehydration, febrile neutropenia, food intolerance, hypophagia, lymphopenia, mucosal inflammation, oropharyngeal pain. Sunitinib dosage: 37.5MG/DAILY ORAL. During the same period patient was treated with PERCOCET, ASPIRIN. Patient was hospitalized. Patient recovered.
Sunitinib Side Effects Report #5848075-7
Sunitinib side effect was reported by a Health Professional from UNITED STATES on Aug 14, 2008. Female patient, weighting 96.89 lb, was diagnosed with head and neck cancer
and was treated with Sunitinib. After drug was administered, patient experienced the following side effects: fall
, fatigue, mucosal inflammation, pyrexia. Sunitinib dosage: 37.5MG/DAILY/PO/QD/PILL. During the same period patient was treated with NEURONTIN, OXYCODONE, PREDNISONE, PRILOSEC, NEXIUM. Patient was hospitalized. Patient recovered.Sunitinib Side Effects Report #5407142-2
Sunitinib side effect was reported by a Health Professional from UNITED STATES on Aug 03, 2007. Male patient, weighting 196.4 lb, was diagnosed with glioblastoma multiforme and was treated with Sunitinib. After drug was administered, patient experienced the following side effects: mucosal inflammation, platelet count decreased. Sunitinib dosage: 50 MG DAILY PO. Patient recovered.
Sunitinib Side Effects Report #6058751-1
Sunitinib side effect was reported by a Pharmacist from SPAIN on Jan 21, 2009. Female patient was diagnosed with breast cancer
and was treated with Sunitinib. After drug was administered, patient experienced the following side effects: mucosal inflammation, neuropathy peripheral, neutropenia, palmar-plantar erythrodysaesthesia syndrome, skin toxicity. Sunitinib dosage: 37.5 MG, 1X/DAY. During the same period patient was treated with SUNITINIB MALATE, DOCETAXEL. Patient was hospitalized. Patient recovered.Sunitinib Side Effects Report #6121861-4
Sunitinib side effect was reported by a Pharmacist from SPAIN on Mar 05, 2009. Female patient was diagnosed with breast cancer
and was treated with Sunitinib. After drug was administered, patient experienced the following side effects: mucosal inflammation, neuropathy peripheral, neutropenia, palmar-plantar erythrodysaesthesia syndrome, skin toxicity. Sunitinib dosage: 37.5 MG, 1X/DAY. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.
Sunitinib and mucosal inflammation 